Description
Deboc-cabazitaxel or De-boc-cabazitaxel is an impurity in the synthesis of cabazitaxel. The latter is an anti-cancer agent derived from taxol. Cabazitaxel is used in the treatment of castration-resistant prostate cancer.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Deboc-cabazitaxel or De-boc-cabazitaxel is an impurity in the synthesis of cabazitaxel. The latter is an anti-cancer agent derived from taxol. Cabazitaxel is used in the treatment of castration-resistant prostate cancer.
| Cas No. | 1638286-64-2 |
|---|---|
| Purity | ≥95% |
| Formula | C40H49NO12 |
| Formula Wt. | 735.83 |
| Synonym | De-boc-Cabazitaxel |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Macrolide; protein synthesis inhibitor.
Synthetic peptide hormone, met-enkephalin analo...
Abl inhibitor.
Renin inhibitor.
Recombinant HIV-1 antigen fragment.
Benzimidazole; microtubule polymerization inhib...
Indirect activator of STING signaling
Taxane synthesis intermediate.
Nucleoside (deoxyadenosine) analog; DNA chain t...
Endogenous pteridine metabolite of GTP.
GSK-3β, HGK, and CDK inhibitor.
Triterpenoid found in Centella.
Negative control for PKC activation.
Triazole; 14-α demethylase inhibitor, potentia...
Fluoroquinolone; topoisomerase IV and bacterial...
FIASMA, mAChR, 5-HT2/3/6/7, α1/2-adrenergic an...
Endogenous peptide hormone, involved in intesti...
Dihydrofolate reductase inhibitor.
Actinomycin derivative used to study apoptosis ...
Endogenous steroid hormone involved in stress s...